Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Diamant

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
Human Brain Mapping|April 22, 2017
Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitusEelco van Duinkerken, Menno M Schoonheim, Richard G IJzerman, et al.
Diabetes Care|June 29, 2014
Ventral striatum, but not cortical volume loss, is related to cognitive dysfunction in type 1 diabetic patients with and without microangiopathyEelco van Duinkerken, Menno M Schoonheim, Martijn D Steenwijk, et al.
Biochimica Et Biophysica Acta|January 24, 2007
Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cellsJolita Ciapaite, Jan van Bezu, Gerco van Eikenhorst, et al.
BMJ Open|November 21, 2015
Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetesMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
Diabetes, Obesity & Metabolism|January 18, 2018
Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trialsLennart Tonneijck, Marcel H A Muskiet, Mark M Smits, et al.
Atherosclerosis|May 25, 2010
One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stressMathijs C Bunck, Anja Cornér, Bjorn Eliasson, et al.
Clinical Pharmacokinetics|December 15, 2010
Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosingMark Fineman, Shawn Flanagan, Kristin Taylor, et al.
Microcirculation (New York, N.Y. : 1994)|January 20, 2019
The presence of cerebral white matter lesions and lower skin microvascular perfusion predicts lower cognitive performance in type 1 diabetes patients with retinopathy but not in healthy controls-A longitudinal studyAnna L Emanuel, Eelco van Duinkerken, Mike P Wattjes, et al.
Diabetes Care|May 1, 2007
Fasting and postprandial glycoxidative and lipoxidative stress are increased in women with type 2 diabetesRoger K Schindhelm, Marjan Alssema, Peter G Scheffer, et al.
Journal of the American College of Cardiology|November 22, 2008
Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitusLuuk J Rijzewijk, Rutger W van der Meer, Johannes W A Smit, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Human Brain Mapping|April 22, 2017
Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitusEelco van Duinkerken, Menno M Schoonheim, Richard G IJzerman, et al.
Diabetes Care|June 29, 2014
Ventral striatum, but not cortical volume loss, is related to cognitive dysfunction in type 1 diabetic patients with and without microangiopathyEelco van Duinkerken, Menno M Schoonheim, Martijn D Steenwijk, et al.
Biochimica Et Biophysica Acta|January 24, 2007
Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cellsJolita Ciapaite, Jan van Bezu, Gerco van Eikenhorst, et al.
BMJ Open|November 21, 2015
Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetesMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
Diabetes, Obesity & Metabolism|January 18, 2018
Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trialsLennart Tonneijck, Marcel H A Muskiet, Mark M Smits, et al.
Atherosclerosis|May 25, 2010
One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stressMathijs C Bunck, Anja Cornér, Bjorn Eliasson, et al.
Clinical Pharmacokinetics|December 15, 2010
Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosingMark Fineman, Shawn Flanagan, Kristin Taylor, et al.
Microcirculation (New York, N.Y. : 1994)|January 20, 2019
The presence of cerebral white matter lesions and lower skin microvascular perfusion predicts lower cognitive performance in type 1 diabetes patients with retinopathy but not in healthy controls-A longitudinal studyAnna L Emanuel, Eelco van Duinkerken, Mike P Wattjes, et al.
Diabetes Care|May 1, 2007
Fasting and postprandial glycoxidative and lipoxidative stress are increased in women with type 2 diabetesRoger K Schindhelm, Marjan Alssema, Peter G Scheffer, et al.
Journal of the American College of Cardiology|November 22, 2008
Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitusLuuk J Rijzewijk, Rutger W van der Meer, Johannes W A Smit, et al.
Pageof 22